Our preclinical data document that this natural anti-Gal antibody can interact with α-gal epitopes expressed on tumor cells within lesions that are injected with α-gal glycolipids, induce their destruction and further induce an active anti-tumor immune response. This evidence concerns the gene GAL and neoplasm.